Logo
M

MedinCell

150 employees

MedinCell is an injectable slow-release drug specialist company.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Pharmaceutical
medical devices
pharmaceutical industry
mental health
controlled release
Polymer chemistry
patient safety
chronic pain
generic
drug delivery
patient care
compliance
R&D
global health
joint ventures
pain control
long acting drug
Health innovation
API

Date founded

2002

Funding rounds raised

Total raised

$42M

from 7 investors over 7 rounds

M

MedinCell raised $42M on November 24, 2022

Investors: European Investment Bank

M

MedinCell raised $36M on February 11, 2021

Investors: BNP Paribas Développement, Seventure Partners, Mirova Natural Capital and Crédit Mutuel Innovation

M

MedinCell raised $19M on November 29, 2019

Investors: Bill & Melinda Gates Foundation

M

MedinCell raised $24M on March 1, 2018

Investors: European Investment Bank

FAQ